Overview

Polyprenols (Ropren) in Acute Coronary Syndrome

Status:
Completed
Trial end date:
2018-02-28
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine efficacy and safety of polyprenols (ROPREN) using in patients with acute coronary syndrome
Phase:
Phase 3
Details
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences